296 related articles for article (PubMed ID: 29848443)
1. ZFP36 RNA-binding proteins restrain T cell activation and anti-viral immunity.
Moore MJ; Blachere NE; Fak JJ; Park CY; Sawicka K; Parveen S; Zucker-Scharff I; Moltedo B; Rudensky AY; Darnell RB
Elife; 2018 May; 7():. PubMed ID: 29848443
[TBL] [Abstract][Full Text] [Related]
2. Global target mRNA specification and regulation by the RNA-binding protein ZFP36.
Mukherjee N; Jacobs NC; Hafner M; Kennington EA; Nusbaum JD; Tuschl T; Blackshear PJ; Ohler U
Genome Biol; 2014 Jan; 15(1):R12. PubMed ID: 24401661
[TBL] [Abstract][Full Text] [Related]
3. The ZFP36 family of RNA binding proteins regulates homeostatic and autoreactive T cell responses.
Cook ME; Bradstreet TR; Webber AM; Kim J; Santeford A; Harris KM; Murphy MK; Tran J; Abdalla NM; Schwarzkopf EA; Greco SC; Halabi CM; Apte RS; Blackshear PJ; Edelson BT
Sci Immunol; 2022 Oct; 7(76):eabo0981. PubMed ID: 36269839
[TBL] [Abstract][Full Text] [Related]
4. Post-Transcriptional Regulation of Immune Responses and Inflammatory Diseases by RNA-Binding ZFP36 Family Proteins.
Makita S; Takatori H; Nakajima H
Front Immunol; 2021; 12():711633. PubMed ID: 34276705
[TBL] [Abstract][Full Text] [Related]
5. Tristetraprolin specifically regulates the expression and alternative splicing of immune response genes in HeLa cells.
Tu Y; Wu X; Yu F; Dang J; Wang J; Wei Y; Cai Z; Zhou Z; Liao W; Li L; Zhang Y
BMC Immunol; 2019 May; 20(1):13. PubMed ID: 31046669
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of the AU-rich RNA-binding protein ZFP36 in chronic HBV patients: implications for anti-inflammatory therapy.
Jin WJ; Chen CF; Liao HY; Gong LL; Yuan XH; Zhao BB; Zhang D; Feng X; Liu JJ; Wang Y; Chen GF; Yan HP; He YW
PLoS One; 2012; 7(3):e33356. PubMed ID: 22428029
[TBL] [Abstract][Full Text] [Related]
7. A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients.
Griseri P; Bourcier C; Hieblot C; Essafi-Benkhadir K; Chamorey E; Touriol C; Pagès G
Hum Mol Genet; 2011 Dec; 20(23):4556-68. PubMed ID: 21875902
[TBL] [Abstract][Full Text] [Related]
8. mRNA-binding protein ZFP36 is expressed in atherosclerotic lesions and reduces inflammation in aortic endothelial cells.
Zhang H; Taylor WR; Joseph G; Caracciolo V; Gonzales DM; Sidell N; Seli E; Blackshear PJ; Kallen CB
Arterioscler Thromb Vasc Biol; 2013 Jun; 33(6):1212-20. PubMed ID: 23559629
[TBL] [Abstract][Full Text] [Related]
9. Post-transcriptional regulation of immune responses by RNA binding proteins.
Mino T; Takeuchi O
Proc Jpn Acad Ser B Phys Biol Sci; 2018; 94(6):248-258. PubMed ID: 29887569
[TBL] [Abstract][Full Text] [Related]
10. Tristetraprolin-RNA interaction map reveals a novel TTP-RelB regulatory network for innate immunity gene expression.
Tu Y; Wu X; Yu F; Dang J; Wei Y; Yu H; Liao W; Zhang Y; Wang J
Mol Immunol; 2020 May; 121():59-71. PubMed ID: 32163759
[TBL] [Abstract][Full Text] [Related]
11. Myeloid-specific deletion of Zfp36 protects against insulin resistance and fatty liver in diet-induced obese mice.
Caracciolo V; Young J; Gonzales D; Ni Y; Flowers SJ; Summer R; Waldman SA; Kim JK; Jung DY; Noh HL; Kim T; Blackshear PJ; O'Connell D; Bauer RC; Kallen CB
Am J Physiol Endocrinol Metab; 2018 Oct; 315(4):E676-E693. PubMed ID: 29509432
[TBL] [Abstract][Full Text] [Related]
12. RNA binding proteins as regulators of immune cell biology.
Newman R; McHugh J; Turner M
Clin Exp Immunol; 2016 Jan; 183(1):37-49. PubMed ID: 26201441
[TBL] [Abstract][Full Text] [Related]
13. ZFP36 disruption is insufficient to enhance the function of mesothelin-targeting human CAR-T cells.
Mai D; Boyce T; Mehta A; Reff J; Scholler J; Sheppard NC; June CH
Sci Rep; 2024 Feb; 14(1):3113. PubMed ID: 38326511
[TBL] [Abstract][Full Text] [Related]
14. Multiomics analysis couples mRNA turnover and translational control of glutamine metabolism to the differentiation of the activated CD4
Matheson LS; Petkau G; Sáenz-Narciso B; D'Angeli V; McHugh J; Newman R; Munford H; West J; Chakraborty K; Roberts J; Łukasiak S; Díaz-Muñoz MD; Bell SE; Dimeloe S; Turner M
Sci Rep; 2022 Nov; 12(1):19657. PubMed ID: 36385275
[TBL] [Abstract][Full Text] [Related]
15. ZFP36-mediated mRNA decay regulates metabolism.
Cicchetto AC; Jacobson EC; Sunshine H; Wilde BR; Krall AS; Jarrett KE; Sedgeman L; Turner M; Plath K; Iruela-Arispe ML; de Aguiar Vallim TQ; Christofk HR
Cell Rep; 2023 May; 42(5):112411. PubMed ID: 37086408
[TBL] [Abstract][Full Text] [Related]
16. The RNA-binding proteins Zfp36l1 and Zfp36l2 act redundantly in myogenesis.
Bye-A-Jee H; Pugazhendhi D; Woodhouse S; Brien P; Watson R; Turner M; Pell J
Skelet Muscle; 2018 Dec; 8(1):37. PubMed ID: 30526691
[TBL] [Abstract][Full Text] [Related]
17. Tristetraprolin inhibits macrophage IL-27-induced activation of antitumour cytotoxic T cell responses.
Wang Q; Ning H; Peng H; Wei L; Hou R; Hoft DF; Liu J
Nat Commun; 2017 Oct; 8(1):867. PubMed ID: 29021521
[TBL] [Abstract][Full Text] [Related]
18. zfp36 expression delineates both myeloid cells and cells localized to the fusing neural folds in Xenopus tropicalis.
Noiret M; Hardy S; Audic Y
Int J Dev Biol; 2014; 58(10-12):751-5. PubMed ID: 26154316
[TBL] [Abstract][Full Text] [Related]
19. Myeloid ZFP36L1 does not regulate inflammation or host defense in mouse models of acute bacterial infection.
Hyatt LD; Wasserman GA; Rah YJ; Matsuura KY; Coleman FT; Hilliard KL; Pepper-Cunningham ZA; Ieong M; Stumpo DJ; Blackshear PJ; Quinton LJ; Mizgerd JP; Jones MR
PLoS One; 2014; 9(10):e109072. PubMed ID: 25299049
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of RNA cap methyltransferase RNMT drives ribosome biogenesis during T cell activation.
Galloway A; Kaskar A; Ditsova D; Atrih A; Yoshikawa H; Gomez-Moreira C; Suska O; Warminski M; Grzela R; Lamond AI; Darzynkiewicz E; Jemielity J; Cowling VH
Nucleic Acids Res; 2021 Jul; 49(12):6722-6738. PubMed ID: 34125914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
